Literature DB >> 8054284

Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.

F Chang1, S Syrjänen, A Tervahauta, K Kurvinen, L Wang, K Syrjänen.   

Abstract

Epidemiological evidence suggests that alcohol intake, use of tobacco, ingestion of mycotoxins and nitrosamines and nutritional deficiencies are high-risk factors for the development of oesophageal cancer. Similarly, viral infections have been postulated to play a role in some tumours. However, the molecular events underlying the development of oesophageal carcinoma are poorly understood as yet. Loss of p53 tumour-suppressor gene function has been found in different human malignancies, and it can occur in a variety of ways, including gene mutation and interaction with the E6 protein of oncogenic human papillomaviruses (HPVs). Because the oesophageal mucosa is potentially exposed to mutagens and HPVs, we studied DNA samples derived from nine HPV-positive squamous cell carcinomas and 12 HPV-negative tumours. Exons 5-9 of the p53 gene containing phylogenetically conserved domains were examined using the polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) technique. HPV detection was done using DNA in situ hybridisation with biotin-labelled HPV DNA probes. Mutations were detected in eight (38%) out of the 21 cases. Three mutations were found in exons 5/6, three in exon 7 and two in exon 8/9. Six (50%) of the 12 HPV-negative carcinomas showed p53 mutations. Two (22.2%) of the nine HPV-positive carcinomas were found to contain p53 mutations as well; one contained HPV 16 DNA sequences and showed p53 mutation in exon 8/9, and the other was HPV 6/11 positive with the mutation in exon 5/6. Although mutations were more common in HPV-negative tumours (50.0% vs 22.2%), the difference in p53 mutations in HPV-positive and -negative tumours did not reach statistical significance (P = 0.1946). These data indicate that inactivation of the p53 gene is a frequent event in oesophageal squamous cell carcinomas and such an inactivation might be an important molecular pathway for the development of oesophageal cancer. The findings of p53 mutations in HPV-positive oesophageal carcinomas suggest that HPV and p53 mutation were not mutually exclusive events. The presence of frequent mutations of p53 gene in both HPV-positive and -negative oesophageal carcinomas suggests a dominant role of environmental carcinogens in oesophageal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054284      PMCID: PMC2033483          DOI: 10.1038/bjc.1994.305

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Frequent mutation of the p53 gene in human esophageal cancer.

Authors:  M C Hollstein; R A Metcalf; J A Welsh; R Montesano; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 3.  The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses.

Authors:  A J Levine
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

4.  A variation in the structure of the protein-coding region of the human p53 gene.

Authors:  V L Buchman; P M Chumakov; N N Ninkina; O P Samarina; G P Georgiev
Journal:  Gene       Date:  1988-10-30       Impact factor: 3.688

5.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

6.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

7.  Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China.

Authors:  F Chang; S Syrjänen; Q Shen; H X Ji; K Syrjänen
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

8.  Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras.

Authors:  J A DiPaolo; C D Woodworth; N C Popescu; V Notario; J Doniger
Journal:  Oncogene       Date:  1989-04       Impact factor: 9.867

9.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.

Authors:  P J Hurlin; P Kaur; P P Smith; N Perez-Reyes; R A Blanton; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

10.  Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes.

Authors:  S Syrjänen; P Partanen; R Mäntyjärvi; K Syrjänen
Journal:  J Virol Methods       Date:  1988 Mar-Apr       Impact factor: 2.014

View more
  9 in total

Review 1.  HPV infections and oesophageal cancer.

Authors:  K J Syrjänen
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

Review 2.  Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.

Authors:  Niladri Ganguly; Suraj P Parihar
Journal:  J Biosci       Date:  2009-03       Impact factor: 1.826

3.  HPV DNA and p53 alterations in oropharyngeal carcinomas.

Authors:  M Barten; C Ostwald; K Milde-Langosch; P Müller; Y Wukasch; T Löning
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 4.  Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Gabriella De Santi; Valentina Rampulla; Antonio Ghidini; Paola Mercurio; Marco Mariani; Michele Manara; Emanuele Rausa; Veronica Lonati; Matteo Viti; Andrea Luciani; Andrea Celotti
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-17       Impact factor: 4.553

5.  The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview.

Authors:  Giuseppe Pannone; Angela Santoro; Silvana Papagerakis; Lorenzo Lo Muzio; Gaetano De Rosa; Pantaleo Bufo
Journal:  Infect Agent Cancer       Date:  2011-03-29       Impact factor: 2.965

6.  P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.

Authors:  T Lasky; E Silbergeld
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

7.  p53 mutations in human papillomavirus-associated oesophageal squamous cell carcinoma.

Authors:  K Cooper
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

8.  Papillomaviruses: a systematic review.

Authors:  Rodrigo Pinheiro Araldi; Suely Muro Reis Assaf; Rodrigo Franco de Carvalho; Márcio Augusto Caldas Rocha de Carvalho; Jacqueline Mazzuchelli de Souza; Roberta Fiusa Magnelli; Diego Grando Módolo; Franco Peppino Roperto; Rita de Cassia Stocco; Willy Beçak
Journal:  Genet Mol Biol       Date:  2017-02-16       Impact factor: 1.771

Review 9.  HPV & head and neck cancer: a descriptive update.

Authors:  Peter K C Goon; Margaret A Stanley; Jörg Ebmeyer; Lars Steinsträsser; Tahwinder Upile; Waseem Jerjes; Manuel Bernal-Sprekelsen; Martin Görner; Holger H Sudhoff
Journal:  Head Neck Oncol       Date:  2009-10-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.